the delivery of equipment or project until this situation can be controlled. Therefore, the operations and delivered projects are delayed, resulting in the decrease of revenue in Q1– 2020. In terms of
the delivery of equipment or project until this situation can be controlled. Therefore, the operations and delivered projects are delayed, resulting in the decrease of revenue in Q1– 2020. In terms of
Infrastructure Trusts (No. 4) dated 6 March 2017 (effective on 1 June 2017). 3 (1) amount and offering price; (2) period of the offering; (3) detail on the subscription, underwriting and allotment of the units; (4
. During the last 4 months of 2017 (September to December), the Company had production not only full capacity during the off-peak period (the period where electricity cost is cheaper), but also extended some
Company also aware of the current situation and has adjusted operations to maintain revenue growth along with consistently enhanced quality and capability of service under cost-effective management to
cost saving measures to minimize the negative impact of the COVID-19 pandemic on the Company’s future operations and is hopeful that appropriate measures will also be taken by the Government to support
. However, the effective cost control helped decrease SG&A expenses, thus overall performance has improved. Bio-based product business The Biodiesel business performance improved from the same period of the
% Effective Finance Cost 3.62% Credit Rating: AA- with stable outlook by TRIS in Sep’19 Net Operating Debt/Equity: 0.66 times 17% 15% 10% 19% 29% 2020 2021 2022 2023 2024 2025 & after 4% 5%LT Loan Debenture LT
% Advertising income 7.52 0.9% 1.85 0.2% 2.71 0.3% 46.5% -64.0% Total revenue from core business (3 items) 848.81 100.0% 798.65 100.0% 804.20 100.0% 0.7% -5.3% Cost of services (664.22) -78.3% (629.36) -78.7
while other non-interest income declined yoy. Overall operating expenses also declined from effective cost management when comparing to the same period last year. The Bank continued to remain prudent when